RxSight, Inc. (RXST): Total Assets
$311.81M
As of 2025-12-31
$352.70M
As of 2026-06-30
+27.6%
3-year compound annual growth
+25.4%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $311.81M | -2.1% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $318.56M | +74.5% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $182.55M | +21.6% | 2025-02-25, Balance as of period end |
| 2022-12-31 | $150.16M | -22.1% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $192.72M | +91.4% | 2023-03-06, Balance as of period end |
| 2020-12-31 | $100.68M | n/a | 2022-03-08, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| RxSight, Inc. (RXST) | 2025-12-31 | $311.81M | -2.1% |
| Staar Surgical Co (STAA) | 2026-01-02 | $451.68M | -11.4% |
| Warby Parker Inc. (WRBY) | 2025-12-31 | $720.92M | +6.6% |
| National Vision Holdings, Inc. (EYE) | 2026-01-03 | $1.98B | -1.2% |
| Cooper Companies, Inc. (COO) | 2025-10-31 | $12.39B | +0.6% |
| Bausch & Lomb Corp (BLCO) | 2025-12-31 | $14.02B | +4.1% |
| Innovative Eyewear Inc (LUCYW) | 2025-12-31 | $10.14M | +3.1% |
Compare RXST, STAA, WRBY, EYE side by side · Screen every company in Ophthalmic Goods ↗